Cell line · CVCL_8916
ST88-14
Cancer cell line, Homo sapiens. Malignant peripheral nerve sheath tumor. 30 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. ST88-14. Cell lines, record CVCL_8916. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_8916
On this page
Cell line
As Cellosaurus gives it.
- Name
- ST88-14
- Accession
- CVCL_8916
- RRID
- RRID:CVCL_8916
- Synonyms
- ST88.14, ST 88-14, ST-8814, ST8814, 88-14, NF188-14
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 24Y
- Category
- Cancer cell line
- Diseases
- Malignant peripheral nerve sheath tumor (NCIt C3798); Neurofibromatosis type 1 (NCIt C3273); Malignant peripheral nerve sheath tumor (ORDO Orphanet_3148); Neurofibromatosis type 1 (ORDO Orphanet_636)
- Derived from
- Retroperitoneal space (in situ)
- Entry created
- 2012-06-06
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers30
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Induced pluripotent stem cell-derived models of malignant nerve sheath tumor progression mimic glial to neuro-mesenchymal transition and uncover therapeutic opportunities. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PRMT5 is Frequently Upregulated and a Potential Therapeutic Target in MTAP-deficient Malignant Peripheral Nerve Sheath Tumors. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Electromagnetic exposure changes human Schwann cell motility and transcriptomic profile of hearing-loss-related genes. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models. | Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | Clin Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities. | Mol Oncol | 2024 | Cellosaurus cites it, and its Methods give the RRID and name the line | PubMed | |
| Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis. | iScience | 2023 | Cellosaurus cites it, and its Methods give the RRID and name the line | PubMed | |
| Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor. | Cell Rep | 2022 | Its Methods give the RRID and name the line | PubMed | |
| PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. | Cancer Discov | 2022 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 30
See all 30 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Derived from it | T265 | CVCL_S805 | Has a recorded problem |
Source Cell lines
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_8916
GET https://conductscience.org/api/cell-lines/v1/CVCL_8916/papers?page=2